Dextenza intraocular and Etodolac Extended-Release Tablets
Determining the interaction of Dextenza intraocular and Etodolac Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
Generic Name: etodolac
Brand name: Lodine, Lodine XL
Synonyms: Etodolac
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza intraocular-Etomidate
- Dextenza intraocular-Etonogestrel
- Dextenza intraocular-Etonogestrel implant
- Dextenza intraocular-Etonogestrel Intradermal
- Dextenza intraocular-Etopophos
- Dextenza intraocular-Etopophos (Etoposide Injection)
- Etodolac Extended-Release Tablets-Dextran 40
- Etodolac Extended-Release Tablets-Dextran 70 6% in 5% Dextrose high molecular weight
- Etodolac Extended-Release Tablets-Dextran 75
- Etodolac Extended-Release Tablets-Dextran high molecular weight
- Etodolac Extended-Release Tablets-Dextranomer and Hyaluronate Derivatives (Deflux)
- Etodolac Extended-Release Tablets-Dextranomer and Hyaluronate Derivatives (Solesta)